Sage Therapeutics Inc Investor Relations Material
Sage Therapeutics, Inc., operates as a biopharmaceutical company, which focuses on the development and commercialization of medicines to treat central nervous system disorders. Its products include, for example, SAGE-547 and SAGE-217
Latest company events
Ticker symbol
SAGE
Country
United States of America
About the company
Investor Relations Page
Dig deeper into the Sage Therapeutics Inc fundamentals on Quartr.
- Conference calls from all over the world
- Search for anything across all transcripts
- Consensus estimates
- Comprehensive financial data
- Read the transcripts or scroll the deck
- Slide decks and earnings reports
